Sort
39,280 grants matching “leukemia”
Transcriptional Regulation by the HTLV-1 Tax Protein
$308,785Colorado State University-Fort Collins · R01 · FY2003 · CA
Targeted Liposomal Doxorubicin Delivery to Leukemia
$308,779Ohio State University · R01 · FY2003 · CA
Targeting NEDD8-Mediated Protein Turnover in AML
$308,756Jennifer S Carew · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Transcriptional regulation of Toll-like receptor signaling
$308,732Youhai H Chen · University Of Pennsylvania · R01 · FY2011 · GM
Development & Dissemination of Education in Pediatric Palliative Care
$308,705Stefan J Friedrichsdorf · Children'S Hospitals And Clinics · R25 · FY2014 · CA
Cell Death Induced by Anticancer Agents
$308,650Dartmouth College · R01 · FY2004 · CA
Structure-Function of Protein Deacetylases
$308,648Wistar Institute · R01 · FY2005 · CA
Subnuclear Targeting and Architectural Epigenetics in Cancer Cells
$308,611Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · CA
Cell Processing and Storage
$308,611Shelly Heimfeld · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA
Subnuclear Targeting and Architectural Epigenetics in Cancer Cells
$308,610Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · CA
A role for c-Abl/Arg in melanoma progression
$308,604Rina Plattner · University Of Kentucky · R01 · FY2016 · CA
A role for c-Abl/Arg in melanoma progression
$308,604Rina Plattner · University Of Kentucky · R01 · FY2015 · CA
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia
$308,596Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
$308,531Stephan A Grupp · Children'S Hosp Of Philadelphia · R01 · FY2007 · CA
Targeting Cell Cycle Machinery For Cancer Therapy
$308,525Temple University · R01 · FY2005 · CA
Targeting Cell Cycle Machinery For Cancer Therapy
$308,525Temple University · R01 · FY2004 · CA
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia
$308,524Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
$308,491Stephan A Grupp · Children'S Hosp Of Philadelphia · R01 · FY2006 · CA
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
$308,475Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
GENE THERAPY FOR ERYTHROPOIETIC PROTOPORPHYRIA
$308,447Brigham And Women'S Hospital · R01 · FY2000 · DK
Embryoid Body-derived Hematopoietic Stem Cell Lines
$308,400American National Red Cross · R01 · FY2002 · HL
Embryoid Body-derived Hematopoietic Stem Cell Lines
$308,400American National Red Cross · R01 · FY2001 · HL
Embryoid Body-derived Hematopoietic Stem Cell Lines
$308,400American National Red Cross · R01 · FY2003 · HL
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer
$308,399Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R34 · FY2025 · CA
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
$308,345Carlo M Croce · Ohio State University · R01 · FY2009 · CA